Neoadjuvant Treatment of Early Triple-negative Breast Cancer With Chidamide and Chemotherapy
Clinical trial NCT04582955 · UNKNOWN
Trial details
- NCT number
- NCT04582955
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-30
- Primary completion
- 2022-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.